- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 209/24 - Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom
Patent holdings for IPC class C07D 209/24
Total number of patents in this class: 155
10-year publication summary
|
18
|
15
|
8
|
13
|
8
|
8
|
7
|
8
|
9
|
3
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of Michigan | 4698 |
7 |
| The Johns Hopkins University | 5667 |
5 |
| Florida Institute of Technology | 16 |
5 |
| The Royal Institution for The Advancement of Learning / McGill University | 689 |
5 |
| Massachusetts Institute of Technology | 10057 |
4 |
| Nanoquantum Sciences, Inc. | 6 |
4 |
| University of Southern California | 2112 |
3 |
| Bionomics Limited | 88 |
3 |
| The Board of Regents for Oklahoma State University | 156 |
3 |
| HQ Medical Netherlands B.V. | 8 |
3 |
| Korea Research Institute of Bioscience and Biotechnology | 1061 |
3 |
| Lumos Pharma, Inc. | 26 |
3 |
| F. Hoffmann-La Roche AG | 7925 |
2 |
| Hoffmann-La Roche Inc. | 3418 |
2 |
| Takeda Pharmaceutical Company Limited | 2713 |
2 |
| Vertex Pharmaceuticals Incorporated | 1597 |
2 |
| Amira Pharmaceuticals, Inc. | 70 |
2 |
| Arcturus Therapeutics, Inc. | 170 |
2 |
| Emory University | 1626 |
2 |
| Kyushu University, National University Corporation | 1657 |
2 |
| Other owners | 91 |